| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.27 | 1e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.26 | 3e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |